Showing results (481-490 of 763) with videos related to
Sort By:
Pageof 77
International Journal of Hypertension|December 20, 2012
Prevalence of hypertension and diabetes and coexistence of chronic kidney disease and cardiovascular risk in the population of the republic of moldovaIgor Codreanu, Vera Sali, Sergiu Gaibu, et al.Blood Purification|July 18, 2017
Therapeutic Plasma Exchange in Neonates and Infants: Successful Use of a Miniaturized MachineEnrico Vidal, Francesco Garzotto, Mattia Parolin, et al.Reviews in Endocrine & Metabolic Disorders|May 4, 2021
In search of an ideal drug for safer treatment of obesity: The false promise of pseudoephedrineAntonio Munafò, Stefano Frara, Norberto Perico, et al.Journal of Hypertension|September 1, 2007
Albuminuria response to very high-dose valsartan in type 2 diabetes mellitusNorman K Hollenberg, Hans-Henrik Parving, Giancarlo Viberti, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 30, 2023
Ofatumumab in Rituximab-Resistant and Rituximab-Intolerant Patients With Primary Membranous Nephropathy: A Case SeriesManuel Alfredo Podestà, Matias Trillini, Valentina Portalupi, et al.Nature Reviews. Nephrology|December 20, 2018
Author Correction: Estimated GFR: time for a critical appraisalEsteban Porrini, Piero Ruggenenti, Sergio Luis-Lima, et al.Arthritis and Rheumatism|May 1, 2007
Involvement of renal tubular Toll-like receptor 9 in the development of tubulointerstitial injury in systemic lupusAriela Benigni, Cristina Caroli, Lorena Longaretti, et al.The American Journal of Pathology|January 10, 2006
Pathophysiologic implications of reduced podocyte number in a rat model of progressive glomerular injuryDaniela Macconi, Maria Bonomelli, Ariela Benigni, et al.Kidney International|March 13, 2003
Effects of combined ACE inhibitor and angiotensin II antagonist treatment in human chronic nephropathiesRuth Campbell, Fabio Sangalli, Elena Perticucci, et al.The American Journal of Pathology|April 28, 2005
In response to protein load podocytes reorganize cytoskeleton and modulate endothelin-1 gene: implication for permselective dysfunction of chronic nephropathiesMarina Morigi, Simona Buelli, Stefania Angioletti, et al.Pageof 77